10 May 2007 Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1)
09 May 2007 Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval
04 May 2007 Pharmexa starts pivotal phase III trial in the United States
04 May 2007 BioMS Medical Completes Patient Recruitment in MINDSET-01 Phase II Relapsing-Remitting Multiple Sclerosis Trial
04 May 2007 Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
04 May 2007 Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
03 May 2007 Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
01 May 2007 Pharmexa and Bavarian Nordic initiates new NIH funded Phase I trial of two HIV vaccines EP1233 and MVA-BN Polytope in combination
01 May 2007 Advaxis Announces Completion of Patient Accrual in Lovaxin C Phase I/II Trial
01 May 2007 Apollo develops needle-free topical vaccine
28 Apr 2007 Optaflu(R), the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval
27 Apr 2007 Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers' Diarrhea Stimulates Immune Response Even at Low Doses
26 Apr 2007 Novartis expands portfolio of respiratory medicines by acquiring rights to a novel therapeutic vaccine against nicotine addiction
20 Apr 2007 Resistentia Initiates Phase II Clinical Testing of Novel Immunotherapeutic for Allergic Asthma
19 Apr 2007 Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
18 Apr 2007 Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
18 Apr 2007 Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
17 Apr 2007 Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
17 Apr 2007 Generex Biotechnology Vaccine Development Programs Presented at the Annual Meeting of the American Association for Cancer Research
17 Apr 2007 Cervarix(R), GSK cervical cancer candidate vaccine, demonstrates 100 percent protection against precancerous lesions caused by cancer-causing human papillomavirus types 16 & 18 for more than five years
12 Apr 2007 Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
06 Apr 2007 BioMS Medicals's Pivotal Multiple Sclerosis Trial Receives Positive Interim Safety Analysis
05 Apr 2007 Regulatory approval to start pediatric clinical trials for Japanese Encephalitis (JE) Vaccine in Ind
05 Apr 2007 CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
04 Apr 2007 Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up